Prevalence of contagious
pustular dermatitis (orf) in six million lambs at slaughter: a three-year study.
(3.) Lotem M, Katzenelson V Rotem A, Hod M, Sandbank M: Impetigo herpetiformis: a variant of
pustular psoriasis or a separate entity?
One tip is to check for lesions on the palms and soles, which can be diagnostic in transient neonatal
pustular melanosis, but not for erythema toxicum.
Subcorneal
pustular dermatosis (Sneddon-Wilkinson disease) occurring in association with nodal marginal zone lymphoma: a case report.
In a patient with severe
pustular psoriasis who presented in 2001 with a significant flare that required hospitalization, infliximab (Remicade) treatment resulted in remarkable clearing (J.
On March 4, a woman aged 18 years with no history of smallpox vaccination reported to a local health department with a 0.5 cm
pustular lesion on her right forearm, surrounded by a nearly 6.0 cm area of erythema.
The bubonic bacillus, Yersinia pestis, carried by flea vectors on rats and other fur-bearing rodent-like animals, upon infecting humans makes its way into the lymphatic system, causing the lymph nodes to bulge and form dark
pustular buboes (hence our colloquial term boo-boo, used to describe childhood injuries).
"But some European dermatologists insist that zinc works on the
pustular kind," which is less common.
AnaptysBio Inc (NASDAQ: ANAB) is due to release Phase 2 data for ANB019 in generalized
pustular psoriasis in mid-2019.
The Company's proprietary anti-inflammatory pipeline includes its anti-IL-33 antibody etokimab, previously referred to as ANB020, for the treatment of moderate-to-severe atopic dermatitis, eosinophilic asthma, and adult chronic rhinosinusitis with nasal polyps, or CRSwNP; its anti-IL-36R antibody ANB019 for the treatment of rare inflammatory diseases, including generalized
pustular psoriasis, or GPP, and palmoplantar pustulosis, or PPP; its PD-1 agonist program, ANB030, and other novel anti-inflammatory checkpoint receptor modulator antibodies for treatment of certain autoimmune diseases where immune checkpoint receptors are insufficiently activated.
AbbVie announced that the Japanese Ministry of Health, Labour and Welfare, or MHLW, has approved SKYRIZI, an interleukin-23 inhibitor, for the treatment of plaque psoriasis, generalized
pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adult patients who have an inadequate response to conventional therapies.
Schachner noted that the differential diagnosis of noninfectious, usually benign neonatal vesiculopustular lesions includes acropustulosis of infancy; eosinophilic
pustular folliculitis; erythema toxicum neonatorum; miliaria crystallina, rubra, or profunda; transient neonatal
pustular melanosis; and neonatal sucking blisters.
